Paushak Ltd

Paushak Limited maintains a strong liquidity position with a current ratio of 2.24, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquidity_fpt score is 0.85, suggesting a relatively stable cash flow position. However, the company has a negative net cash position after subtracting total debt, which may pose a liquidity risk in the short term. In terms of profitability, Paushak Limited reports a return on equity (ROE) of 10.61% and a return on assets (ROA) of 8.63%. These figures are above the industry median ROE of 8.2% and ROA of 6.5%, indicating that the company is generating higher returns relative to its equity and total assets. The company's operating margin is 21.2%, which is also above the industry median of 18.5%, suggesting efficient cost management and strong pricing power. The company's revenue is primarily concentrated in India, with 95% of its total revenue derived from domestic operations. Internationally, the company has limited exposure, with only 5% of revenue coming from other regions. This concentration may expose the company to regulatory and economic risks specific to India, such as changes in import/export policies or currency fluctuations. Looking at the growth trajectory, Paushak Limited is projected to see a 12% increase in revenue in the current fiscal year and a 15% increase in the next fiscal year. This growth is driven by increased demand in the pharmaceutical and agrochemical sectors, as well as the company's expansion into new product lines. The company's capital expenditure is expected to remain high, with a projected 18% increase in the next fiscal year to support this growth. The company faces several risk factors, including liquidity risk due to its negative net cash position and the potential for dilution if the company issues additional shares. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has not issued any new shares in the past year, and there are no immediate plans for dilution. However, the company may need to raise additional capital to fund its expansion, which could lead to dilution in the future. Recent events include the company's 2023 annual report, which highlights its financial performance and strategic initiatives. The report also outlines the company's commitment to ESG principles, with a governance pillar score of 61.5 and a social pillar score of 49.9. The company has not faced any major controversies in the past year, and its ESG controversies score remains at 100.0.